FTC sues big pharmacy gain professionals about insulin prices The agency brought action towards Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the listing cost of lifetime-saving insulin medicines. The offer should be done by Sept. 30 or potential buyers can terminate the https://juliusskaqh.theideasblog.com/31083898/healthcare-news-secrets